FDA approves a Precigen BLA for Papzimeos (zopapogene imadenovec-drba), a non-replicating adenoviral vector-based immunotherapy for treating adult pat...
FDA issues an alert after becoming aware that Medtronic recently sent a letter to customers recommending that certain DLP Left Heart Vent Catheters be...
A Phase 3 study of Pfizers investigational sickle cell disease drug inclacumab fails to meet the primary endpoint.
FDA grants Beam Therapeutics a Regenerative Medicine Advanced Therapy designation for BEAM-101, an investigational gene-edited cell treatment for sick...
The Multidisciplinary Association for Psychedelic Studies calls on HHS and FDA to quickly approve its NDA for MDMA-assisted therapy that was rejected ...
President Trump issues an Executive Order requiring HHS to obtain critical drug active pharmaceutical ingredients to be stored in a strategic reserve.
After two deaths in trial, Schrdinger decides to stop developing SGR-2921, its CDC7 inhibitor being evaluated in a Phase 1 dose-escalation study.
FDA grants Halda Therapeutics a Fast Track designation for HLD-0915 and its use for treating metastatic castration-resistant prostate cancer.
